Extrapulmonary Presentations of COVID-19 Patients

Extrapulmonary Presentation of COVID-19 Patients During the Second Wave

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04896762

Enrollment

948

Registered

2021-05-21

Start date

2020-09-01

Completion date

2022-12-31

Last updated

2022-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Keywords

extrapulmonary presentation, pulmonary

Brief summary

An observational study about the extrapulmonary presentations of COVID-19 patients during the second wave of the pandemic.

Detailed description

a prospective observational study that aimed at 1. provide an overview about the prevalence of extra-pulmonary presentation of COVID-19 during the second wave of the pandemic and 2. Detection of the most frequent affected systems with comparison between the pulmonary and extrapulmonary presentation of COVID 19 as regard patient demographics, comorbidity and level of care needed.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* all patient with confirmed covid 19 disease presented to our health facility during the second wave of the pandemic

Exclusion criteria

* other diagnosis than covid 19 as a primary cause of presentation of the patient

Design outcomes

Primary

Measure	Time frame	Description
extrapulmonary presentation in COVID-19	Baseline presentation of confirmed cases with COVID-19	frequency of extrapulmonary presentation inCOVID-19 second wave pandemic

Countries

Egypt

Outcome results